Homoeopathy for adult patient with hives and skin allergy

A double-blind, randomized, placebo-controlled trial of Individualised Homoeopathic Medicines in Adults with Chronic Spontaneous urticaria - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093481

Enrollment

130

Registered

2025-08-22

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L50- Urticaria

Interventions

Intervention1: Individualized homeopathic medicines plus Concomitant care: Intervention is planned as administering indicated homoeopathic medicines in centesimal potencies (CH). Each dose will consis

dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing their teeth w

Eligibility

Inclusion criteria

Inclusion criteria: 1.Cases suffering from already diagnosed CSU (EB00.1 is the ICD-11 code) with UAS7 score: mild =7-15; moderate= 16-27 2.Age between 18 and 65 years. 3.Participants of either sex.

Exclusion criteria

Exclusion criteria: 1.Participant having UAS7 score: less than 7 and more than 27 2.Non- Providing written informed consent voluntarily. 3.Patients using regular conventional anti-allergic medication and/or glucocorticoid steroids. 4.Vulnerable population- Unconscious, non-ambulatory, too sick for consultation, differently abled, terminally ill or critically ill patients, mentally incompetent people. 5.Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled systemic illness or life-threatening illness affecting quality of life or any organ failure. 6.Patient having a history of severe anaphylactic shock. 7.Pregnancy, puerperium, lactation. 8.Patient under tobacco chewing and/or smoking, alcoholism and/or any other form(s) of substance abuse and/or dependence. 9.Immune-compromised state AIDS, Hepatitis &c. 10.Undergoing homoeopathic treatment for any chronic disease within last 6 months. 11.Simultaneous participation in any other clinical trial

Design outcomes

Primary

Measure	Time frame
To determine the group differences in the Hives severity score (HSS) of adults with CSU at baseline and after 4 months of intervention.Timepoint: Baseline, and every week , upto 4 months.	—

Secondary

Measure	Time frame
Itch Severity Score (ISS) using UAS7 questionnaireTimepoint: Baseline, and every week , upto 4 months.;CU-Q2oL questionnaireTimepoint: Every month , upto 4 months.;Measure Yourself Medical Outcome-Profile version 2 (MYMOP-2) questionnaireTimepoint: Every month , upto 4 months.	—

Countries

India

Contacts

Public ContactSubhasish Ganguly

D.N.De Homoeopathic Medical college and Hospital

drpoojapandey5982@gmail.com9038341444

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026